Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease

Why Did Tarenflurbil Fail in Alzheimer's Disease?

(2017) Bruno P. Imbimbo   JOURNAL OF ALZHEIMERS DISEASE

2016 Alzheimer's disease facts and figures

(2016)   Alzheimers & Dementia

Mitochondrial respiration is sensitive to cytoarchitectural breakdown

(2016) Judith Kandel et al.   Integrative Biology

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

(2015) M. Elizabeth Meredith et al.   AAPS Journal

Brain–blood ratio: implications in brain drug delivery

(2015) Abhijeet D Kulkarni et al.   Expert Opinion on Drug Delivery

Alterations in mitochondrial number and function in Alzheimer’s disease fibroblasts

(2015) Nora E. Gray et al.   METABOLIC BRAIN DISEASE

The Alzheimer disease market

(2015) XiaoXiao Qian et al.   NATURE REVIEWS DRUG DISCOVERY

Non-steroidal anti-inflammatory drugs (NSAIDs) and neuroprotection in the elderly: a view from the mitochondria

(2015) Carlos Villalobos et al.   Neural Regeneration Research

Intranasal therapeutic strategies for management of Alzheimer’s disease

(2014) Sumeet Sood et al.   JOURNAL OF DRUG TARGETING

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy

(2014) Shuko Takeda et al.   Frontiers in Aging Neuroscience

Direct nose to brain drug deliveryviaintegrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting

(2013) Chandrakantsing Vijaysing Pardeshi et al.   Expert Opinion on Drug Delivery

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

(2013) Usman A Khan et al.   NATURE NEUROSCIENCE

Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model

(2013) Sabrina Meister et al.   Alzheimers Research & Therapy

Integration of cellular bioenergetics with mitochondrial quality control and autophagy

(2012) Bradford G. Hill et al.   BIOLOGICAL CHEMISTRY

Intranasal delivery of biologics to the central nervous system

(2011) Jeffrey J. Lochhead et al.   ADVANCED DRUG DELIVERY REVIEWS

Albumin-based nanoparticles as potential controlled release drug delivery systems

(2011) Ahmed O. Elzoghby et al.   JOURNAL OF CONTROLLED RELEASE

Anatomy and physiology of cerebrospinal fluid

(2011) L. Sakka et al.   European Annals of Otorhinolaryngology-Head and Neck Diseases

Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease

(2010) Clara Hiu-Ling Hung et al.   AGEING RESEARCH REVIEWS

Effect of Bovine Serum Albumin on Mitochondrial Respiration in the Brain and Liver of Mice and Rats

(2010) A. V. Panov et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network

(2010) Julie A. Harris et al.   NEURON

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month international multi-center phase 3 trial

(2009) Gordon K. Wilcock et al.   Alzheimers & Dementia

Spare respiratory capacity, oxidative stress and excitotoxicity

(2009) David G. Nicholls   BIOCHEMICAL SOCIETY TRANSACTIONS

Mitochondria, calcium and cell death: A deadly triad in neurodegeneration

(2009) Fulvio Celsi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept

(2009) Andreas Reichel   CHEMISTRY & BIODIVERSITY

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial

(2009) Robert C. Green   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Brain delivery of proteins by the intranasal route of administration: A comparison of cationic liposomes versus aqueous solution formulations

(2009) Mattia M. Migliore et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

(2009) J. Yao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

(2008) Leah R Hanson et al.   BMC NEUROSCIENCE

The antioxidant properties of serum albumin

(2008) Marjolaine Roche et al.   FEBS LETTERS

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

(2008) Gordon K Wilcock et al.   LANCET NEUROLOGY

Mitochondrial Ca2+ Overload Underlies Aβ Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs

(2008) Sara Sanz-Blasco et al.   PLoS One

What Does the Anatomical Organization of the Entorhinal Cortex Tell Us?

(2008) Cathrin B. Canto et al.   NEURAL PLASTICITY